197 related articles for article (PubMed ID: 32198624)
1. Outcomes and prognostic factors of patients with recurrent and persistent malignant ovarian germ cell tumors.
Wang J; Zhuo X; Yang J; Cao D; Shen K; Huang H; Wu M; Pan L; Xiang Y; Guo L
Arch Gynecol Obstet; 2020 Apr; 301(4):1021-1026. PubMed ID: 32198624
[TBL] [Abstract][Full Text] [Related]
2. Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.
Mangili G; Sigismondi C; Gadducci A; Cormio G; Scollo P; Tateo S; Ferrandina G; Greggi S; Candiani M; Lorusso D
Int J Gynecol Cancer; 2011 Nov; 21(8):1414-21. PubMed ID: 21795985
[TBL] [Abstract][Full Text] [Related]
3. The impact of lymphadenectomy on prognosis and survival of clinically apparent early-stage malignant ovarian germ cell tumors.
Qin B; Xu W; Li Y
Jpn J Clin Oncol; 2020 Mar; 50(3):282-287. PubMed ID: 31867612
[TBL] [Abstract][Full Text] [Related]
4. Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2017 Jun; 145(3):513-518. PubMed ID: 28372870
[TBL] [Abstract][Full Text] [Related]
5. Treatment of malignant ovarian germ cell tumors and preservation of fertility.
Zhang R; Sun YC; Zhang GY; Wu LY; Zuo J
Eur J Gynaecol Oncol; 2012; 33(5):489-92. PubMed ID: 23185794
[TBL] [Abstract][Full Text] [Related]
6. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
[TBL] [Abstract][Full Text] [Related]
7. Current Strategy for the Treatment of Ovarian Germ Cell Tumors: Role of Extensive Surgery.
Li J; Wu X
Curr Treat Options Oncol; 2016 Aug; 17(8):44. PubMed ID: 27357180
[TBL] [Abstract][Full Text] [Related]
8. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY
World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930
[TBL] [Abstract][Full Text] [Related]
9. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
[TBL] [Abstract][Full Text] [Related]
10. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
Yang ZJ; Liu ZC; Wei RJ; Li L
Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
Li J; Yang W; Wu X
Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
[TBL] [Abstract][Full Text] [Related]
12. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
[TBL] [Abstract][Full Text] [Related]
13. Outcome and prognostic factors in ovarian germ cell malignancies.
Lai CH; Chang TC; Hsueh S; Wu TI; Chao A; Chou HH; Wang PN
Gynecol Oncol; 2005 Mar; 96(3):784-91. PubMed ID: 15721426
[TBL] [Abstract][Full Text] [Related]
14. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
[TBL] [Abstract][Full Text] [Related]
15. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group.
Billmire DF; Cullen JW; Rescorla FJ; Davis M; Schlatter MG; Olson TA; Malogolowkin MH; Pashankar F; Villaluna D; Krailo M; Egler RA; Rodriguez-Galindo C; Frazier AL
J Clin Oncol; 2014 Feb; 32(5):465-70. PubMed ID: 24395845
[TBL] [Abstract][Full Text] [Related]
16. Outcome of recurrent and persistent disease of malignant ovarian germ cell tumor: a retrospective analysis at King Chulalongkorn Memorial Hospital.
Lertkhachonsuk R; Manchana T; Termrungruanglert W; Vasuratna A; Sittisomwong T; Worasethsin P; Sirisabya N; Khemapech N; Tresukosol D
J Med Assoc Thai; 2006 Feb; 89(2):138-44. PubMed ID: 16578998
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological pattern and outcome of pediatric malignant ovarian germ cell tumors: South Egypt Cancer Institute experience.
Ali A; Sayed H; Salem M; Hamdy M; Farok A
J Pediatr Surg; 2018 Apr; 53(4):837-840. PubMed ID: 28919321
[TBL] [Abstract][Full Text] [Related]
18. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
19. Malignant ovarian germ cell tumor in King Chulalongkorn Memorial Hospital.
Lertkhachonsuk R; Termrungruanglert W; Vasuratna A; Sittisomwong T; Worasethsin P; Tresukosol D
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S124-8. PubMed ID: 16623016
[TBL] [Abstract][Full Text] [Related]
20. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017.
Park M; Lim J; Lee JA; Park HJ; Park BK; Lim MC; Park SY; Won YJ
Gynecol Oncol; 2021 Oct; 163(1):79-84. PubMed ID: 34392955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
